September 26, 2018
Statement on UN High-Level Meeting on TB
The world is listening and expecting true commitment and change
September 19, 2018
TB Alliance and Liverpool School of Tropical Medicine Collaborate to Develop New TB Therapies
New partnership supported by Medical Research Council to research drug regimens to fight drug-resistant tuberculosis
September 18, 2018
Once Again, New TB Numbers Underscore the Need for New Treatments
Statement from TB Alliance on WHO Global TB Report 2018
August 28, 2018
SimpliciTB Clinical Trial Launched with First Patients in Tbilisi, Georgia
New pivotal trial examines potential of BPaMZ regimen to shorten treatment for tuberculosis and multidrug-resistant tuberculosis
August 17, 2018
TB Alliance Statement on WHO Rapid Communication Regarding MDR-TB Treatment
Forthcoming Recommendations Point to Treatment Changes for Drug-Resistant TB
July 13, 2018
TB Alliance Names Angela Vanderploeg as Chief Financial Officer
Vanderploeg Brings Comprehensive Financial Management Experience to Help Guide Pursuit of Life-Saving New Tuberculosis Therapies
July 6, 2018
In Memory of Professor Denis Mitchison
Statement from TB Alliance
June 5, 2018
Statement on Civil Society Hearing on the UN High Level Meeting on Tuberculosis
PDPs urge commitment to tripling the overall annual investments in TB R&D
June 4, 2018
TB Alliance Names Sandeep Juneja as Senior Vice President for Market Access
Juneja Brings Industry Expertise to Initiatives that Accelerate Access to New TB Drug Regimens
April 26, 2018